hotspot -WSS

hotspot

author：leisure time 2025-10-01 05:38:29 - browse：757

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Diagnostic tests are hitting their mathematical limits

focus

leisure time

WSS

CDC Director Mandy Cohen on transparency, trust, and health

Rep. Raul Ruiz on the physician shortage and more

A new crop of companies is reshaping the health data economy

What causes rare myocarditis in young men after Covid vaccines?

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

What to watch for from Zogenix and Amicus clinical trials

focus

hotspot

focus

Apple is now the first public company to be valued at $3 trillion

With clinical trial data readouts, here's how to spot spin

Alkermes shareholders re

Senate panel puts off hardest PBM reforms for another day

Heart attack and stroke risk calculators need revising

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Psychedelics group wrestles with new pharma identity

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Tori Bowie and the unacceptable rates of Black maternal death

Former reverend arrested for allegedly killing 8

focus

Rise in cancer among younger people worries and puzzles doctors

Diagnostic tests are hitting their mathematical limits

30 years of 'Listening to Prozac'

What to watch for from Zogenix and Amicus clinical trials

As biotech industry slumps, bioscience job market is upside down

The EPA's new lead rule: How one expert crunched the numbers

focus

focus

leisure time

leisure time